8-K
Current Report
Keros Therapeutics, Inc. Filed Acc 0001664710-21-000040
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading keros-form8xk2021shmeeting.htm…